Clinical Trials Browser

Unknown × OTHER × Carcinoma, Non-Small-Cell Lung × Clear all

NCT04767009 2025-04-30

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05599789 2025-02-18

KeyPemls-004

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06496360 2024-08-07

Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Phase 1 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03724500 2024-05-22

Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT06394427 2024-05-01

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05260606 2024-04-17

IBFIC

Carcinoma, Non-Small-Cell Lung

NCT06357598 2024-04-10

PILOT

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06349252 2024-04-05

Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06344962 2024-04-03

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT06341530 2024-04-02

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06341660 2024-04-02

To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06331650 2024-03-26

A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02619448 2024-03-25

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06326086 2024-03-22

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

Carcinoma, Non-Small-Cell Lung, Sarcopenia

NCT03322072 2024-03-20

GPS

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06285058 2024-03-13

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

Carcinoma, Non-Small-Cell Lung

NCT06277674 2024-03-08

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06293833 2024-03-05

ZORALCS

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking Cessation, Small Cell Lung Carcinoma

NCT03865511 2024-02-28

MELROSE

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06281860 2024-02-28

PITHAC

Phase 1 Unknown

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06267144 2024-02-20

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05602259 2024-02-09

PROTEON

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06250829 2024-02-09

Pre-PLaN

Carcinoma, Non-Small-Cell Lung

NCT05573373 2024-01-31

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05647590 2024-01-30

SBRT/RT in Oligometastatic Stage IV NSCLC

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06228508 2024-01-29

BiliBro

Carcinoma, Non-Small-Cell Lung

NCT06207292 2024-01-16

STARTNEWERA-OM

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05296278 2024-01-10

Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05248022 2024-01-09

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06195683 2024-01-08

NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04789252 2024-01-02

TUM-DC

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Neoplasms

NCT04937972 2023-12-29

FLYFLY

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05611879 2023-12-29

Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02098954 2023-12-27

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03646994 2023-12-27

Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT03647111 2023-12-27

Real World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT03647592 2023-12-27

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04071418 2023-12-27

RISIRLC

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04322591 2023-12-27

POSEIDON

Carcinoma, Non-Small-Cell Lung

NCT04397432 2023-12-27

SELECT-1

Carcinoma, Non-Small-Cell Lung

NCT04401059 2023-12-27

SELECT-2

Phase 4 Unknown

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06182800 2023-12-27

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT06180239 2023-12-22

Segmentectomy vs Lobectomy

Carcinoma, Non-Small-Cell Lung

NCT02950337 2023-12-21

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT06163846 2023-12-20

Image Mining and ctDNA to Improve Risk Stratification and Outcome Prediction in NSCLC Applying Artificial Intelligence.

Carcinoma, Non-Small-Cell Lung

NCT05542485 2023-12-15

PLAN

Carcinoma, Non-Small-Cell Lung